You are here

Hot stock: Best World International's shares surge 14.8% on licence to sell products in China

38691898 - 13_06_2016 - CHINA-STOCKS_.jpg

MAINBOARD-LISTED Best World International said on Friday morning its subsidiary, Best World (Zhejiang) Pharmaceutical, has been granted the direct selling licence by the Ministry of Commerce in China.

News of the grant sparked a surge in the shares of the skincare and wellness product manufacturer, making it one of the top 20 gainers on Singapore Exchange.

As at 3.28pm, its counter rose 14.8 per cent or 17 Singapore cents to S$1.32.

Under the licence granted on Thursday, Best World (Zhejiang) Pharmaceutical will be permitted to sell directly its products in China. The specifics as to what categories of products and where in China it can do so will be announced in due course, the group said.

Pursuant to the grant of the licence, Best World (Zhejiang) Pharmaceutical is not permitted to start direct selling of its products until the company sets up the requisite service centres in Hangzhou city within six months from June 7, 2016. These service centres will be subjected to the Chinese authorities' inspection.

Your feedback is important to us

Tell us what you think. Email us at

Best World (Zhejiang) Pharmaceutical is a wholly owned subsidiary of Best World International's wholly owned subsidiary, Best World Lifestyle.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to